CN213108506U

CN213108506U - Novel antiviral fabric

Info

Publication number: CN213108506U
Application number: CN202021468266.6U
Authority: CN
Inventors: 黄振亚; 陈海连
Original assignee: Shenzhen Dingshang Textile Co Ltd
Current assignee: Shenzhen Dingshang Textile Co Ltd
Priority date: 2020-07-22
Filing date: 2020-07-22
Publication date: 2021-05-04
Anticipated expiration: 2030-07-22

Abstract

The utility model relates to a novel antiviral fabric belongs to textile material 'S technical field, including the surface fabric body, the surface fabric body has set gradually inlayer surface fabric, outer surface fabric, graphite alkene nexine, face yarn intermediate layer and silver ion membrane from inside to outside, the face yarn intermediate layer is 20S-50S' S antiviral combed cotton yarn, antiviral combed cotton yarn is by cotton fiber through grafting modification process processing preparation, the antibiotic combed cotton yarn of non-leachability biology, the graphite alkene nexine is the interior warm viscose cotton yarn that glues that contains the graphite alkene composition. The anti-virus fabric has the effects of reducing the harm of the anti-virus auxiliary agent in the fabric body to a human body and improving the anti-virus capacity of the fabric body.

Description

Novel antiviral fabric

Technical Field

The application relates to the field of textile materials, in particular to a novel antiviral fabric.

Background

The prior fabric is used for making clothes, and different fabrics have different functions and can adapt to wearing of human bodies in special occasions.

In the existing market, part of fabrics have an antiviral function, and the antiviral function is realized by adding an antiviral auxiliary agent through subsequent finishing.

With respect to the related art among the above, the inventors consider that the following drawbacks exist: the anti-additive added in the after-finishing is not washable, and antiviral substances can be dissolved out after washing, so that the skin of a human body can be allergic and uncomfortable.

SUMMERY OF THE UTILITY MODEL

In order to reduce the injury of anti-virus auxiliary agent in the fabric body to the human body, improve the antiviral ability of fabric body simultaneously, this application provides a novel antiviral fabric.

The application provides a novel antiviral surface fabric adopts following technical scheme:

the novel anti-virus fabric comprises a fabric body, wherein the fabric body is sequentially provided with an inner layer fabric, an outer layer fabric, a graphene inner layer, a face yarn interlayer and a silver ion film from inside to outside, the face yarn interlayer is anti-virus combed cotton yarn with a yarn count specification of 20S-50S, the anti-virus combed cotton yarn is non-dissoluble biological antibacterial combed cotton yarn which is prepared by cotton fiber through a graft modification process, and the graphene inner layer is inner warm viscose cotton yarn containing graphene components.

By adopting the technical scheme, the silver ions have the effects of sterilizing without damaging beneficial bacteria and normal cells, the face yarn interlayer is made of anti-virus combed cotton yarn and has the functions of inhibiting bacteria and resisting viruses, the graphene inner layer is an intelligent multifunctional fiber new material formed by compounding biomass graphene and inner warm viscose cotton yarn, the intelligent multifunctional fiber new material has the functions of low temperature and far infrared, and has the functions of resisting bacteria, inhibiting bacteria, resisting ultraviolet rays, absorbing moisture, ventilating and promoting microcirculation.

Preferably, the silver ion membrane has a honeycomb structure.

Through adopting above-mentioned technical scheme, the setting of honeycomb structure not only plays save material's effect, and the effectual intensity that improves silver ion membrane moreover to guarantee silver ion membrane's structural stability.

Preferably, a plurality of micropores which are uniformly distributed are formed in one side, close to the outer-layer fabric, of the graphene inner layer.

By adopting the technical scheme, the micropores are densely distributed on the graphene inner layer, so that the outer layer fabric is tightly connected with the graphene inner layer, a differential capillary effect is formed between the graphene inner layer and the outer layer fabric, and the diffusion of sweat generated by a human body is facilitated.

Preferably, an adhesive layer is arranged between the inner-layer fabric and the outer-layer fabric, and the inner-layer fabric and the outer-layer fabric are connected and compounded through the adhesive layer.

By adopting the technical scheme, the arrangement of the bonding layer is used for bonding the inner layer fabric and the outer layer fabric together.

Preferably, the bonding layer comprises yarns and spandex yarns, the spandex yarns are wound with the adjacent yarns in parallel, the yarns are Modal yarns, and the spandex yarns are fusible spandex yarns.

By adopting the technical scheme, the Dare yarn and the fusible spandex yarn are wound in parallel to form the bonding layer, and the fusible spandex yarn is slightly fused after being heated, so that the contact part of the spandex yarn and the Dare yarn has viscosity, and the aim of bonding the inner-layer fabric and the outer-layer fabric is fulfilled.

Preferably, the inner fabric is formed by plain weaving of the elastic covering yarns.

By adopting the technical scheme, the plain woven inner-layer fabric is firm in structure and compact in texture.

Preferably, the elastic covering yarn comprises a polyester yarn and a spandex yarn; the polyester yarn is spirally wrapped outside the spandex yarn.

By adopting the technical scheme, the polyester yarn has elasticity but is easy to break, the spandex yarn is not easy to break but has poor elasticity, and the polyester yarn and the spandex yarn are spirally wrapped to form the wrapping yarn according to a certain process, so that the wrapping yarn has elasticity and is not easy to break.

Preferably, one side of the inner layer fabric, which is far away from the outer layer fabric, is provided with a plain weave structure.

Through adopting above-mentioned technical scheme, human skin is pressed close to the inlayer surface fabric, and the setting of plain weave structure makes the inlayer surface fabric laminate human skin more.

In summary, the present application includes at least one of the following beneficial technical effects:

1. compared with the fabric only added with the antiviral auxiliary agent, the fabric body sequentially provided with the inner layer fabric, the outer layer fabric, the graphene inner layer, the veil interlayer and the silver ion membrane from inside to outside has the effects of reducing the harm of the antiviral auxiliary agent in the fabric body to a human body and improving the antiviral capacity of the fabric body.

Drawings

Fig. 1 is a schematic cross-sectional structure of the present application.

Description of reference numerals: 1. a fabric body; 11. inner layer fabric; 12. an adhesive layer 13 and an outer layer fabric; 14. a graphene inner layer; 15. a face yarn interlayer; 16. a silver ion membrane.

Detailed Description

The present application is described in further detail below with reference to fig. 1.

The embodiment of the application discloses a novel antiviral fabric. As shown in fig. 1, the fabric comprises a fabric body 1, wherein the fabric body 1 is sequentially provided with an inner fabric 11, an adhesive layer 12, an outer fabric 13, a graphene inner layer 14, a veil interlayer 15 and a silver ion membrane 16 from inside to outside.

As shown in fig. 1, the inner layer fabric 11 is woven by elastic covering yarn, and in order to make the inner layer fabric 11 firm in structure and compact in texture, the inner layer fabric 11 is woven in a plain weave, so that the side of the inner layer fabric 11 away from the outer layer fabric 13 is in a plain weave structure, so as to achieve the effect of making the inner layer fabric 11 fit the skin of a human body better; the elastic covering yarn comprises elastic polyester yarn and unbreakable spandex yarn; the polyester yarn is spirally wrapped outside the spandex yarn.

As shown in fig. 1, the adhesive layer 12 includes a plurality of yarns and a plurality of spandex filaments; the yarns are Modal yarns, the spandex yarns are fusible spandex yarns, a plurality of Modal yarns and a plurality of fusible spandex yarns on the same weft are arranged in a mutually parallel and staggered mode, a plurality of Modal yarns and a plurality of fusible spandex yarns on the same warp are arranged in a mutually parallel and staggered mode, a plurality of Modal yarns on the same warp are wound with the Modal yarns and the fusible spandex yarns on the weft in a cross mode, and a plurality of fusible spandex yarns on the same warp are wound with the Modal yarns and the fusible spandex yarns on the weft in a cross mode. After the temperature is raised, the fusible spandex filaments are slightly melted, so that the contact parts of the spandex filaments and the Darl yarns have viscosity, and the purpose of bonding the inner-layer fabric 11 and the outer-layer fabric 13 is achieved.

As shown in fig. 1, the graphene inner layer 14 is inner warm viscose cotton yarn containing graphene components, and the graphene content is 11-20%; micropores are densely distributed on one side, close to the outer layer fabric 13, of the graphene inner layer 14, and the densely distributed micropores enable the outer layer fabric 13 to be tightly connected with the graphene inner layer 14, so that the dissipation of sweat generated by a human body is facilitated.

As shown in fig. 1, the face yarn interlayer 15 is an antiviral combed cotton yarn with a yarn count specification of 20S-50S, and the antiviral combed cotton yarn is a non-leachable biological antibacterial combed cotton yarn prepared by processing cotton fibers through a graft modification process.

As shown in figure 1, the silver ion membrane 16 has the functions of sterilization and virus resistance, the silver ion membrane 16 can sterilize without damaging beneficial bacteria and normal cells because most of pathogenic bacteria are unicellular microorganisms, and depend on protease to maintain metabolism and propagate to influence normal cells, and an oxygen metabolism enzyme is also contained in the protease, when silver meets the oxygen metabolism enzyme, the activity of the oxygen metabolism enzyme can rob away an electron of the silver, so that silver atoms are changed into positively charged silver ions, and the silver ions attract the specific combination of thiol groups (-SH) with negative charges in the protease to effectively puncture the cell wall and the cell membrane appearance, further, bacterial cells cannot breathe, metabolize and propagate until death due to protein denaturation, and the sterilization effect is achieved. In order to improve the overall strength of the silver ion membrane 16, and to ensure the structural stability of the silver ion membrane 16 while saving materials, the silver ion membrane 16 is configured to have a honeycomb structure.

The implementation principle of the novel antiviral fabric provided by the embodiment of the application is as follows: the inner fabric 11 and the outer fabric 13 are bonded together through the bonding layer 12, and then the graphene inner layer 14, the veil interlayer 15 and the silver ion membrane 16 are sequentially bonded on one surface of the outer fabric 13, which is far away from the inner fabric 11, from inside to outside, so that the formed fabric body 1 reduces the damage of the anti-virus auxiliary agent in the fabric body 1 to a human body, and simultaneously improves the anti-virus capability effect of the fabric body 1.

The above embodiments are preferred embodiments of the present application, and the protection scope of the present application is not limited by the above embodiments, so: all equivalent changes made according to the structure, shape and principle of the present application shall be covered by the protection scope of the present application.

Claims

1. A novel antiviral fabric is characterized in that: including surface fabric body (1), surface fabric body (1) has set gradually inlayer surface fabric (11), outer surface fabric (13), graphite alkene nexine (14), face yarn intermediate layer (15) and silver ionic membrane (16) from inside to outside, face yarn intermediate layer (15) are the antiviral combed cotton yarn that the yarn count specification is 20S-50S, antiviral combed cotton yarn is by cotton fiber through graft modification process processing preparation, the antibiotic combed cotton yarn of non-leachability biology, graphite alkene nexine (14) are the interior warm viscose cotton yarn that contains the graphite alkene composition.

2. The novel antiviral fabric as claimed in claim 1, wherein: the silver ion membrane (16) is of a honeycomb structure.

3. The novel antiviral fabric as claimed in claim 1, wherein: and a plurality of uniformly distributed micropores are formed in one side of the graphene inner layer (14) close to the outer layer fabric (13).

4. The novel antiviral fabric as claimed in claim 1, wherein: an adhesive layer (12) is arranged between the inner layer fabric (11) and the outer layer fabric (13), and the inner layer fabric (11) and the outer layer fabric (13) are connected and compounded through the adhesive layer (12).

5. The novel antiviral fabric as claimed in claim 4, wherein: the bonding layer (12) comprises yarns and spandex yarns, the spandex yarns are wound with the adjacent yarns in parallel, the yarns are Modal yarns, and the spandex yarns are fusible spandex yarns.

6. The novel antiviral fabric as claimed in claim 4, wherein: the inner layer fabric (11) is formed by plain weaving through elastic covering yarns.

7. The novel antiviral fabric as claimed in claim 6, wherein: the elastic coating yarn comprises a polyester yarn and a spandex yarn; the polyester yarn is spirally wrapped outside the spandex yarn.

8. The novel antiviral fabric as claimed in claim 7, wherein: one side of the inner layer fabric (11) far away from the outer layer fabric (13) is set to be of a plain weave structure.